Cargando…
TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulate...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496592/ https://www.ncbi.nlm.nih.gov/pubmed/36140341 http://dx.doi.org/10.3390/biomedicines10092240 |
_version_ | 1784794307432022016 |
---|---|
author | Baranašić, Jurica Šutić, Maja Catalano, Calogerina Drpa, Gordana Huhn, Stefanie Majhen, Dragomira Nestić, Davor Kurtović, Matea Rumora, Lada Bosnar, Martina Vukić Dugac, Andrea Sokolović, Irena Popovic-Grle, Sanja Oršolić, Nada Škrinjarić-Cincar, Sanda Jakopović, Marko Samaržija, Miroslav Weber, Alexander N. R. Försti, Asta Knežević, Jelena |
author_facet | Baranašić, Jurica Šutić, Maja Catalano, Calogerina Drpa, Gordana Huhn, Stefanie Majhen, Dragomira Nestić, Davor Kurtović, Matea Rumora, Lada Bosnar, Martina Vukić Dugac, Andrea Sokolović, Irena Popovic-Grle, Sanja Oršolić, Nada Škrinjarić-Cincar, Sanda Jakopović, Marko Samaržija, Miroslav Weber, Alexander N. R. Försti, Asta Knežević, Jelena |
author_sort | Baranašić, Jurica |
collection | PubMed |
description | Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case–control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5(N592S) was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5(WT) or TLR5(N592S), respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance. |
format | Online Article Text |
id | pubmed-9496592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94965922022-09-23 TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line Baranašić, Jurica Šutić, Maja Catalano, Calogerina Drpa, Gordana Huhn, Stefanie Majhen, Dragomira Nestić, Davor Kurtović, Matea Rumora, Lada Bosnar, Martina Vukić Dugac, Andrea Sokolović, Irena Popovic-Grle, Sanja Oršolić, Nada Škrinjarić-Cincar, Sanda Jakopović, Marko Samaržija, Miroslav Weber, Alexander N. R. Försti, Asta Knežević, Jelena Biomedicines Article Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case–control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5(N592S) was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5(WT) or TLR5(N592S), respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance. MDPI 2022-09-09 /pmc/articles/PMC9496592/ /pubmed/36140341 http://dx.doi.org/10.3390/biomedicines10092240 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Baranašić, Jurica Šutić, Maja Catalano, Calogerina Drpa, Gordana Huhn, Stefanie Majhen, Dragomira Nestić, Davor Kurtović, Matea Rumora, Lada Bosnar, Martina Vukić Dugac, Andrea Sokolović, Irena Popovic-Grle, Sanja Oršolić, Nada Škrinjarić-Cincar, Sanda Jakopović, Marko Samaržija, Miroslav Weber, Alexander N. R. Försti, Asta Knežević, Jelena TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title | TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title_full | TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title_fullStr | TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title_full_unstemmed | TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title_short | TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line |
title_sort | tlr5 variants are associated with the risk for copd and nsclc development, better overall survival of the nsclc patients and increased chemosensitivity in the h1299 cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496592/ https://www.ncbi.nlm.nih.gov/pubmed/36140341 http://dx.doi.org/10.3390/biomedicines10092240 |
work_keys_str_mv | AT baranasicjurica tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT suticmaja tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT catalanocalogerina tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT drpagordana tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT huhnstefanie tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT majhendragomira tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT nesticdavor tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT kurtovicmatea tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT rumoralada tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT bosnarmartina tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT vukicdugacandrea tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT sokolovicirena tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT popovicgrlesanja tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT orsolicnada tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT skrinjariccincarsanda tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT jakopovicmarko tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT samarzijamiroslav tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT weberalexandernr tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT forstiasta tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline AT knezevicjelena tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline |